SMCZ Faces Unlimited Loss Risk After SMCI Earnings
Defiance’s 2X inverse ETF tied to SMCI confronts a classic risk now that SMCI has reported after hours. The fund’s da...
This piece explains glide path withdrawal strategies for index funds, focusing on steady income while managing sequence of returns risk.
25,847 articlesDefiance’s 2X inverse ETF tied to SMCI confronts a classic risk now that SMCI has reported after hours. The fund’s da...
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
In April, Oklo delivered a sharp rebound that captured investor attention. This in-depth look explains the catalysts,...
Investors chase the next big move in crypto. This guide shows how to spot a cryptocurrency before soars much, plus a ...
A tiny biotech just beat AbbVie's blockbuster in early-stage results, prompting fresh questions about the durability ...
Cerebras signals an upcoming IPO as it presses to outpace Nvidia and rival AI-chip startups in the fast-moving genera...
Bitcoin failed to sustain above $80,000, renewing selling pressure and eyeing lower support. Here’s how the setup cou...
Lam Research sits at the core of AI infrastructure tooling. This article explores whether the company could research ...
Two AI models clash on XRP's path to $3 by Q4 as regulatory, liquidity, and macro factors shape divergent bets from t...
Solana continues a stubborn rebound, trading in the upper-$80s as traders eye a move past $100 and toward $120. On-ch...
Tilray’s pivot to CBD and alcohol sparks questions about profitability and risk. This guide cuts through the hype, of...
Three fast-casual names—Chipotle, Cava Group, and Sweetgreen—sit at the center of today’s restaurant stock debate. Th...